Grossmann M, Wong R, Teh N G, Tropea J E, East-Palmer J, Weintraub B D, Szkudlinski M W
Department of Medicine, University of Maryland Medical School, Baltimore 21201, USA.
Endocrinology. 1997 Jan;138(1):92-100. doi: 10.1210/endo.138.1.4897.
To obtain large amounts of hTSH and to study the role of the N-linked oligosaccharides for its biological activity, hTSH was produced using recombinant baculovirus containing the human alpha-subunit and a hTSH beta-minigene, respectively, both under the control of the polyhedrin promoter. Expression in insect cells was 800-1000 ng/ml, 30-fold higher than in our optimized mammalian transient transfection system using Chinese hamster ovary (CHO) cells (20-50 ng/ml). The in vitro activity of insect-cell expressed hTSH (IC-hTSH) was increased 5-fold compared with CHO-hTSH, judged by the ability to induce cAMP production in CHO cells stably transfected with the hTSH receptor (JP09) and the rat thyroid cell line FRTL-5, as well as growth promotion in FRTL-5 cells. Lectin binding and enzymatic desialylation studies suggested that in contrast to CHO-hTSH, IC-hTSH lacked complex-type oligosaccharides terminating with sialic acid but contained predominantly high mannose-type oligosaccharides. The in vitro activity of CHO-hTSH also increased 5- to 6-fold upon treatment of the hTSH-producing cells with the oligosaccharide processing inhibitors swainsonine and castanospermine, which inhibit formation of complex, terminally sialylated oligosaccharides, and upon enzymatic desialylation. In contrast, insect cell-expression or treatment with processing inhibitors did not affect TSH receptor binding. Despite the higher in vitro activity, IC-hTSH had a much lower in vivo activity than CHO-hTSH, due to rapid clearance from the circulation. In summary, this study shows for the first time that relatively high levels of recombinant hTSH with high in vitro bioactivity can be produced in a baculovirus system. Cell-dependent glycosylation is a major factor that determines the final in vivo biopotency of recombinant glycoproteins, a finding that should be of general relevance for all insect cell-produced glycosylated proteins. Although not suitable for clinical use, highly bioactive recombinant hTSH derived from high expression in insect cells should be useful in defining structure-function relations of hormone analogs.
为了获得大量的人促甲状腺激素(hTSH)并研究N-连接寡糖对其生物活性的作用,分别使用含有人类α亚基和hTSHβ-小基因的重组杆状病毒在多角体蛋白启动子的控制下生产hTSH。在昆虫细胞中的表达量为800 - 1000 ng/ml,比我们使用中国仓鼠卵巢(CHO)细胞的优化哺乳动物瞬时转染系统(20 - 50 ng/ml)高30倍。通过在稳定转染了hTSH受体(JP09)的CHO细胞和大鼠甲状腺细胞系FRTL - 5中诱导cAMP产生的能力以及FRTL - 5细胞中的生长促进作用来判断,昆虫细胞表达的hTSH(IC - hTSH)的体外活性比CHO - hTSH增加了5倍。凝集素结合和酶促去唾液酸化研究表明,与CHO - hTSH相反,IC - hTSH缺乏以唾液酸结尾的复合型寡糖,但主要含有高甘露糖型寡糖。在用寡糖加工抑制剂苦马豆素和澳洲栗精胺处理产生hTSH的细胞后,CHO - hTSH的体外活性也增加了5至6倍,这两种抑制剂可抑制复合型、末端唾液酸化寡糖的形成,并且在酶促去唾液酸化后也是如此。相比之下,昆虫细胞表达或用加工抑制剂处理并不影响TSH受体结合。尽管体外活性较高,但由于从循环中快速清除,IC - hTSH的体内活性比CHO - hTSH低得多。总之,本研究首次表明在杆状病毒系统中可以产生具有高体外生物活性的相对高水平的重组hTSH。细胞依赖性糖基化是决定重组糖蛋白最终体内生物效能的主要因素,这一发现对于所有昆虫细胞产生的糖基化蛋白都应具有普遍意义。虽然不适合临床使用,但在昆虫细胞中高表达产生的具有高生物活性的重组hTSH在确定激素类似物的结构 - 功能关系方面应该是有用的。